{"id":7506,"date":"2024-08-31T13:09:02","date_gmt":"2024-08-31T05:09:02","guid":{"rendered":"https:\/\/regask.com\/?p=7506"},"modified":"2024-09-25T02:19:23","modified_gmt":"2024-09-24T18:19:23","slug":"taller-sobre-medicamentos-genericos-de-la-fda-2024","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/fda-2024-generic-drug-workshop\/","title":{"rendered":"Plan de la FDA de EE. UU. para impulsar el desarrollo de medicamentos gen\u00e9ricos en 2024..."},"content":{"rendered":"<p>El Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos (CDER) de la FDA y la Asistencia para Peque\u00f1as Empresas e Industrias (SBIA) organizar\u00e1n el muy esperado Taller sobre el avance del desarrollo de medicamentos gen\u00e9ricos 2024 los d\u00edas 24 y 25 de septiembre de 2024.<\/p>\n<p>Este taller es una oportunidad esencial para que los profesionales de la industria de medicamentos gen\u00e9ricos se mantengan informados sobre los \u00faltimos avances cient\u00edficos y regulatorios. Ya sea que asistan en persona o de manera virtual, los participantes se ir\u00e1n con conocimientos pr\u00e1cticos y una mejor comprensi\u00f3n del panorama futuro del desarrollo de medicamentos gen\u00e9ricos.<\/p>\n<p><strong>\u00c1reas de enfoque del taller<\/strong><\/p>\n<p>El taller profundizar\u00e1 en temas cr\u00edticos esenciales para el avance de la industria de medicamentos gen\u00e9ricos, incluidos:<\/p>\n<ul>\n<li><strong>Avances en la caracterizaci\u00f3n in vitro<\/strong>:Explore las \u00faltimas metodolog\u00edas que mejoran la caracterizaci\u00f3n in vitro de medicamentos gen\u00e9ricos.<\/li>\n<li><strong>Investigaci\u00f3n para el desarrollo de la orientaci\u00f3n<\/strong>:Comprenda las iniciativas de investigaci\u00f3n de la FDA destinadas a desarrollar orientaci\u00f3n para productos complejos.<\/li>\n<li><strong>Garantizar la calidad y la eficiencia<\/strong>:Conozca los esfuerzos en curso para garantizar el desarrollo eficiente y la alta calidad de medicamentos gen\u00e9ricos.<\/li>\n<\/ul>\n<p>Los participantes tambi\u00e9n obtendr\u00e1n una comprensi\u00f3n m\u00e1s profunda del impacto del Programa de Investigaci\u00f3n y Ciencia de las Enmiendas a las Tarifas para Usuarios de Medicamentos Gen\u00e9ricos (GDUFA) de la FDA en el desarrollo, la regulaci\u00f3n y la aprobaci\u00f3n de medicamentos gen\u00e9ricos.<\/p>\n<p><strong>Horario del taller<\/strong><\/p>\n<ul>\n<li><strong>D\u00eda 1<\/strong>: 24 de septiembre de 2024, de 8:30 a. m. a 4:35 p. m., hora del Este<\/li>\n<li><strong>D\u00eda 2<\/strong>: 25 de septiembre de 2024, de 9:00 a. m. a 4:15 p. m., hora del Este<\/li>\n<\/ul>\n<a href=\"https:\/\/regask.com\/es\/contacto\/\" target=\"_blank\" class=\"button primary is-link is-medium\" rel=\"noopener\" >\n\t\t<span>Para leer m\u00e1s<\/span>\n\t<\/a>\n\n<p>\u00a9Esta alerta de registro es emitida por RegASK<\/p>","protected":false},"excerpt":{"rendered":"<p>The FDA&#8217;s Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) is set to host the highly anticipated 2024 Advancing Generic Drug Development Workshop on September 24-25, 2024. This workshop is an essential opportunity for professionals in the generic drug industry to stay informed on the latest scientific and regulatory advancements&#8230;.<\/p>","protected":false},"author":22,"featured_media":7511,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[177,193,299,481,482,483],"class_list":["post-7506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-labelling","tag-fda","tag-regulatory-intelligence","tag-generic-drugs","tag-webinar","tag-workshop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA&#039;s 2024 Generic Drug Workshop: Key Insights | RegASK<\/title>\n<meta name=\"description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/taller-sobre-medicamentos-genericos-de-la-fda-2024\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA&#039;s 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals\" \/>\n<meta property=\"og:description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/taller-sobre-medicamentos-genericos-de-la-fda-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-31T05:09:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T18:19:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"keywords\":[\"Labelling\",\"FDA\",\"Regulatory Intelligence\",\"Generic Drugs\",\"Webinar\",\"Workshop\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"name\":\"FDA's 2024 Generic Drug Workshop: Key Insights | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"description\":\"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"width\":1600,\"height\":1200,\"caption\":\"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Taller sobre medicamentos gen\u00e9ricos de la FDA de 2024: conclusiones clave | RegASK","description":"El taller sobre el avance del desarrollo de medicamentos gen\u00e9ricos de la FDA de 2024 es fundamental para los profesionales de la industria. Conozca las conclusiones clave con RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/taller-sobre-medicamentos-genericos-de-la-fda-2024\/","og_locale":"es_ES","og_type":"article","og_title":"US FDA's 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals","og_description":"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.","og_url":"https:\/\/regask.com\/es\/taller-sobre-medicamentos-genericos-de-la-fda-2024\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-08-31T05:09:02+00:00","article_modified_time":"2024-09-24T18:19:23+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","type":"image\/png"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"wordCount":232,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","keywords":["Labelling","FDA","Regulatory Intelligence","Generic Drugs","Webinar","Workshop"],"articleSection":["Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","url":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","name":"Taller sobre medicamentos gen\u00e9ricos de la FDA de 2024: conclusiones clave | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","description":"El taller sobre el avance del desarrollo de medicamentos gen\u00e9ricos de la FDA de 2024 es fundamental para los profesionales de la industria. Conozca las conclusiones clave con RegASK.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","width":1600,"height":1200,"caption":"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=7506"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7506\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/7511"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=7506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=7506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=7506"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}